Literature DB >> 24806185

Resistance to arsenic therapy in acute promyelocytic leukemia.

Hong-Hu Zhu1, Ya-Zhen Qin, Xiao-Jun Huang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24806185     DOI: 10.1056/NEJMc1316382

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  36 in total

Review 1.  The influence of subclonal resistance mutations on targeted cancer therapy.

Authors:  Michael W Schmitt; Lawrence A Loeb; Jesse J Salk
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

Review 2.  Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.

Authors:  Miguel A Sanz; Pierre Fenaux; Martin S Tallman; Elihu H Estey; Bob Löwenberg; Tomoki Naoe; Eva Lengfelder; Hartmut Döhner; Alan K Burnett; Sai-Juan Chen; Vikram Mathews; Harry Iland; Eduardo Rego; Hagop Kantarjian; Lionel Adès; Giuseppe Avvisati; Pau Montesinos; Uwe Platzbecker; Farhad Ravandi; Nigel H Russell; Francesco Lo-Coco
Journal:  Blood       Date:  2019-02-25       Impact factor: 22.113

3.  FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias.

Authors:  Cécile Esnault; Ramy Rahmé; Kim L Rice; Caroline Berthier; Coline Gaillard; Samuel Quentin; Anne-Lise Maubert; Scott Kogan; Hugues de Thé
Journal:  Blood       Date:  2019-01-23       Impact factor: 22.113

4.  Genomic landscapes of breast fibroepithelial tumors.

Authors:  Jing Tan; Choon Kiat Ong; Weng Khong Lim; Cedric Chuan Young Ng; Aye Aye Thike; Ley Moy Ng; Vikneswari Rajasegaran; Swe Swe Myint; Sanjanaa Nagarajan; Saranya Thangaraju; Sucharita Dey; Nur Diyana Md Nasir; Giovani Claresta Wijaya; Jing Quan Lim; Dachuan Huang; Zhimei Li; Bernice Huimin Wong; Jason Yong Sheng Chan; John R McPherson; Ioana Cutcutache; Gregory Poore; Su Ting Tay; Wai Jin Tan; Thomas Choudary Putti; Buhari Shaik Ahmad; Philip Iau; Ching Wan Chan; Anthony P H Tang; Wei Sean Yong; Preetha Madhukumar; Gay Hui Ho; Veronique Kiak Mien Tan; Chow Yin Wong; Mikael Hartman; Kong Wee Ong; Benita K T Tan; Steven G Rozen; Patrick Tan; Puay Hoon Tan; Bin Tean Teh
Journal:  Nat Genet       Date:  2015-10-05       Impact factor: 38.330

5.  LG-362B targets PML-RARα and blocks ATRA resistance of acute promyelocytic leukemia.

Authors:  X Wang; Q Lin; F Lv; N Liu; Y Xu; M Liu; Y Chen; Z Yi
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528

6.  Functional Profiling Identifies Determinants of Arsenic Trioxide Cellular Toxicity.

Authors:  Amin Sobh; Alex Loguinov; Gulce Naz Yazici; Rola S Zeidan; Abderrahmane Tagmount; Nima S Hejazi; Alan E Hubbard; Luoping Zhang; Chris D Vulpe
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

Review 7.  Secondary mutations as mediators of resistance to targeted therapy in leukemia.

Authors:  Naval Daver; Jorge Cortes; Farhad Ravandi; Keyur P Patel; Jan A Burger; Marina Konopleva; Hagop Kantarjian
Journal:  Blood       Date:  2015-03-20       Impact factor: 22.113

8.  Characteristics of doxorubicin-selected multidrug-resistant human leukemia HL-60 cells with tolerance to arsenic trioxide and contribution of leukemia stem cells.

Authors:  Jing Chen; Hulai Wei; Jie Cheng; Bei Xie; Bei Wang; Juan Yi; Baoying Tian; Zhuan Liu; Feifei Wang; Zhewen Zhang
Journal:  Oncol Lett       Date:  2017-11-06       Impact factor: 2.967

Review 9.  p53 as an Effector or Inhibitor of Therapy Response.

Authors:  Julien Ablain; Brigitte Poirot; Cécile Esnault; Jacqueline Lehmann-Che; Hugues de Thé
Journal:  Cold Spring Harb Perspect Med       Date:  2015-12-04       Impact factor: 6.915

Review 10.  Differentiation therapy revisited.

Authors:  Hugues de Thé
Journal:  Nat Rev Cancer       Date:  2017-12-01       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.